Graduated in Pharmacy and Biochemistry from Faculdades Oswaldo Cruz, in 2023. Co-founder and Director of the Treasury of the League of Pharmaceutical Genetics of Faculdades Oswaldo Cruz, in 2020 and 2021. President of the League of Pharmaceutical Genetics of Faculdades Oswaldo Cruz, in 2022. Accomplished Scientific initiation in the area of Clinical Research and Kidney Transplantation with a FAPESP scholarship. Completed the Pharmacy course with the course completion work THE USE OF IMMUNOTHERAPY AS A TREATMENT OF NEOPLASMS, approved in December 2023. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The number of kidney transplants performed in sensitized patients has increased recently, reaching about 28% of kidney transplantation in our center. The incidence of acute antibody-mediated -rejection (AMR) under standard triple therapy (Tacrolimus, Mycophenolate Mofetil, and Prednisone) has been elevated in this population. The idea of evaluating the effectiveness of adding a fourth imm…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID